tiprankstipranks
Trending News
More News >
Sintx Technologies Inc (SINT)
NASDAQ:SINT

Sintx Technologies (SINT) AI Stock Analysis

Compare
985 Followers

Top Page

SI

Sintx Technologies

(NASDAQ:SINT)

Rating:42Neutral
Price Target:
Sintx Technologies struggles with financial and operational challenges, evident in its negative profitability and cash flow issues. The technical indicators suggest a bearish sentiment, while its valuation metrics are weak due to ongoing losses. These factors collectively contribute to a low overall stock score.
Positive Factors
Cash Position
The company ended Q1 with $7 million in cash and no debt, raising ~$5 million selling stock, believed to have enough cash into 2026.
Company Valuation
The current valuation is attractive, maintaining a BUY rating with a price target adjusted to $28, representing significant upside from the current share price.
Market Potential
The company is aiming for wide commercial opportunities across medical and non-medical industries for silicon nitride, indicating a large market potential.
Negative Factors
Guidance Uncertainty
Management again declined to provide forward guidance, which can create uncertainty for investors.
Revenue Forecast
There is an uncertain timeline for meaningful growth from more spinal implant sales or from initial revenue from selling new medical products made from advanced ceramics such as silicon nitride.
Revenue Performance
Revenue was $0.4 million, compared with estimates of $0.6 – 0.9 million, and net loss was $2.3 million or EPS of $(1.29), compared with estimates of $(0.71) – (0.80).

Sintx Technologies (SINT) vs. SPDR S&P 500 ETF (SPY)

Sintx Technologies Business Overview & Revenue Model

Company DescriptionSintx Technologies (SINT) is a materials science company specializing in the research, development, and commercialization of advanced ceramics for biomedical and technical applications. The company focuses on creating silicon nitride-based products that are used in various sectors, including medical implants, industrial applications, and defense. Sintx aims to leverage its expertise in ceramics to deliver high-performance solutions that enhance durability and functionality in challenging environments.
How the Company Makes MoneySintx Technologies generates revenue primarily through the sale of its silicon nitride ceramics products. The company's core revenue streams include the medical sector, where it provides materials for orthopedic and spinal implants, and the industrial sector, where its ceramics are used in wear-resistant and high-temperature applications. Additionally, Sintx pursues collaborative partnerships and licensing agreements with other companies to expand the applications of its technology and increase its market reach. These partnerships often involve joint development projects that can lead to new revenue opportunities. Sintx's focus on innovation and the development of new applications for its materials is a key factor in driving its earnings.

Sintx Technologies Financial Statement Overview

Summary
Sintx Technologies faces significant financial challenges, with ongoing losses and cash flow deficits despite revenue growth. The balance sheet reflects rising leverage and moderate equity levels. While there are positive signs in revenue increase and financing capabilities, substantial operational and profitability hurdles persist.
Income Statement
45
Neutral
Sintx Technologies has shown a positive revenue growth trend from $2627k to $2887k in 2024, marking a 9.89% increase year-over-year. However, the company continues to face significant profitability issues with a gross profit margin of 71.94% but a net profit margin of -38.19%, as expenses remain high relative to revenue. The EBIT and EBITDA margins are also negative, indicating ongoing operational challenges.
Balance Sheet
50
Neutral
The debt-to-equity ratio has increased to 1.03, suggesting rising leverage, which could pose risks amid persistent losses. The equity ratio stands at 41.36%, showing a moderate reliance on equity financing. Despite net losses, the company's liquidity remains somewhat stable, with cash and short-term investments covering more than half of its liabilities.
Cash Flow
40
Negative
Free cash flow remains negative, though there has been a reduction in the deficit from -$14.6M in 2023 to -$9.3M in 2024. The operating cash flow to net income ratio is negative, reflecting challenges in converting income to cash flow. Despite a positive financing cash flow, the company's ability to generate cash from operations remains a concern.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue2.57M2.89M2.63M601.00K606.00K594.00K
Gross Profit1.39M2.08M1.84M336.00K157.00K119.00K
EBITDA-11.53M-9.61M-6.60M-11.06M-8.63M-6.53M
Net Income-12.43M-11.02M-8.26M-16.49M-9.82M-7.31M
Balance Sheet
Total Assets11.45M9.41M15.37M15.77M21.84M30.45M
Cash, Cash Equivalents and Short-Term Investments6.50M3.60M3.34M6.25M14.27M25.35M
Total Debt3.50M4.03M4.25M2.89M2.40M2.28M
Total Liabilities5.36M5.52M6.59M10.07M4.11M4.64M
Stockholders Equity6.09M3.89M8.77M5.70M17.73M25.80M
Cash Flow
Free Cash Flow-7.79M-9.33M-14.64M-11.67M-13.87M-9.47M
Operating Cash Flow-7.21M-8.64M-14.12M-10.26M-10.13M-9.11M
Investing Cash Flow-84.00K-194.00K-501.00K-1.10M-1.65M1.75M
Financing Cash Flow8.03M9.09M11.71M3.34M705.00K30.93M

Sintx Technologies Technical Analysis

Technical Analysis Sentiment
Positive
Last Price3.33
Price Trends
50DMA
2.89
Positive
100DMA
2.96
Positive
200DMA
3.16
Positive
Market Momentum
MACD
0.11
Negative
RSI
62.82
Neutral
STOCH
49.17
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For SINT, the sentiment is Positive. The current price of 3.33 is above the 20-day moving average (MA) of 3.10, above the 50-day MA of 2.89, and above the 200-day MA of 3.16, indicating a bullish trend. The MACD of 0.11 indicates Negative momentum. The RSI at 62.82 is Neutral, neither overbought nor oversold. The STOCH value of 49.17 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for SINT.

Sintx Technologies Risk Analysis

Sintx Technologies disclosed 42 risk factors in its most recent earnings report. Sintx Technologies reported the most risks in the "Tech & Innovation" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

Sintx Technologies Peers Comparison

Overall Rating
UnderperformOutperform
Sector (50)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
ZBZBH
69
Neutral
$18.61B20.847.31%1.02%3.30%-2.39%
50
Neutral
kr5.37B12.51-80.61%5.13%37.36%27.71%
49
Neutral
$1.60B-291.71%25.53%23.22%
49
Neutral
$438.04M-27.82%5.85%-8.92%
42
Neutral
$8.00M-155.20%9.90%94.56%
* Healthcare Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
SINT
Sintx Technologies
3.33
-1.17
-26.00%
ATEC
Alphatec Holdings
10.96
0.67
6.51%
OFIX
Orthofix
11.06
-2.45
-18.13%
ZBH
Zimmer Biomet Holdings
93.50
-13.52
-12.63%

Sintx Technologies Corporate Events

Executive/Board Changes
Sintx Technologies Appoints New Chairman of the Board
Neutral
Mar 13, 2025

On March 7, 2025, SINTX Technologies, Inc. appointed Eric K. Olson as the new Chairman of the Board of Directors, succeeding B. Sonny Bal, who remains on the board. This leadership change marks a significant shift in the company’s governance structure, potentially impacting its strategic direction and stakeholder relations.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 20, 2025